Chris Brinsmead

Chris is chairman of the board at Proveca Ltd, Bioscript Ltd and Peakdata AG. He is a non-executive director of Optibiotox Plc and ILC Therapeutics Ltd and a partner at EOS LLC. He has extensive non-executive board experience serving on public, private and charity boards in Life Sciences and other sectors following a 30-year executive career with AstraZeneca.

Chris was appointed a CBE in January 2015 for services to Life Science.